Table 1.
Suggested Hematologic Malignancies Follow-Up After Persistent Complete Remission Achievement
| Disease | Suggested Follow-Up | 
|---|---|
| Aplastic anemia and other non-malignant diseases  | 
● annual CBC | 
| Lymphoma and chronic lymphocytic leukemia  | 
● annual chest X-Ray (if symptoms or previous localization) and abdomen US in indolent lymphomas, up to 5 years after HSCT, then only if clinically indicated ● periodic peripheral lymph nodes palpation for all others223  | 
| Acute leukemia, myelodysplastic and myeloproliferative syndromes | ● annual CBC ● bone marrow examination with search for minimal residual disease up to 5 year after HSCT (3, 6, 12, 18, 24 months after HSCT, annual after second year post-transplant)  | 
| Multiple myeloma | ● serum protein electrophoresis, serum free-light chain ratio, urine and serum immunofixation every 6 months ● imaging only if symptoms  | 
Abbreviations: CBC, complete blood count; US, ultrasound; HSCT, hematopoietic stem-cell transplant.